Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Unaudited NAV for May 2023
Unaudited NAV for May 2023
Unaudited NAV for May 2023
eqs_en 
0 09.06.23
Correction: Result of Annual General Meeting
Correction: Result of Annual General Meeting
Correction: Result of Annual General Meeting
eqs_en 
0 24.05.23
Result of Annual General Meeting
Result of Annual General Meeting
Result of Annual General Meeting
eqs_en 
0 23.05.23
Portfolio company Ensoma announces closing of Series B Extension
Portfolio company Ensoma announces closing of Series B Extension
Portfolio company Ensoma announces closing of Series B Extension
eqs_en 
0 16.05.23
Unaudited NAV for April 2023
Unaudited NAV for April 2023
Unaudited NAV for April 2023
eqs_en 
0 12.05.23
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
eqs_en 
0 27.04.23
Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM
Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM
Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM
eqs_en 
0 25.04.23
Full Year results now to be released on 25 April 2023
Full Year results now to be released on 25 April 2023
Full Year results now to be released on 25 April 2023
eqs_en 
0 19.04.23
Unaudited NAV for March 2023
Unaudited NAV for March 2023
Unaudited NAV for March 2023
eqs_en 
0 17.04.23
Notice of Results and Investor Presentation
Notice of Results and Investor Presentation
Notice of Results and Investor Presentation
eqs_en 
0 14.04.23
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
eqs_en 
0 28.03.23
Form 8.3 - Maitland Institutional Services Limited: Re Reabold Resources Plc
Form 8.3 - Maitland Institutional Services Limited: Re Reabold Resources Plc
Form 8.3 - Maitland Institutional Services Limited: Re Reabold Resources Plc
eqs_en 
0 16.03.23
Unaudited NAV for February 2023
Unaudited NAV for February 2023
Unaudited NAV for February 2023
eqs_en 
0 16.03.23
Portfolio company Disc Medicine announces $62.5 million financing
Portfolio company Disc Medicine announces $62.5 million financing
Portfolio company Disc Medicine announces $62.5 million financing
eqs_en 
0 14.02.23
Unaudited NAV for January 2023
Unaudited NAV for January 2023
Unaudited NAV for January 2023
eqs_en 
0 06.02.23
Unaudited NAV for December 2022
Unaudited NAV for December 2022
Unaudited NAV for December 2022
eqs_en 
0 30.01.23
Board Change
Board Change
Board Change
eqs_en 
0 26.01.23
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
eqs_en 
0 05.01.23
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
eqs_en 
0 30.12.22
Unaudited NAV for November 2022
Unaudited NAV for November 2022
Unaudited NAV for November 2022
eqs_en 
0 12.12.22
Arix to Present at Mello Investment Trusts & Funds
Arix to Present at Mello Investment Trusts & Funds
Arix to Present at Mello Investment Trusts & Funds
eqs_en 
0 06.12.22
Unaudited NAV for October 2022
Unaudited NAV for October 2022
Unaudited NAV for October 2022
eqs_en 
0 09.11.22
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
eqs_en 
0 20.10.22
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
eqs_en 
0 14.10.22
Unaudited NAV for September 2022
Unaudited NAV for September 2022
Unaudited NAV for September 2022
eqs_en 
0 11.10.22